FTSE Russell Summit Therapeutics (2596D)

TIDMSUMM

RNS Number : 2596D

FTSE Russell

17 February 2020

Summit Therapeutics (UK): Constituent Deletion

Changes in FTSE UK Index Series

17 February 2020

 
 Subject to the expected cancellation of trading on AIM for Summit Therapeutics (UK, constituent), 
  please see details of affected indexes and effective dates below: 
 
 
          Index              Effective From 
                             Start of Trading 
 FTSE AIM All-Share Index   24 February 2020 
 
 
 
 
 
 For further information please contact FTSE Russell Client Services at info@ftserussell.com 
                             or call: Australia    +1800 653 680 
                                  Hong Kong    +852 2164 3333 
                                 Japan        +81 3 4563 6346 
                               London       +44 (0) 20 7866 1810 
                                  New York     +1866 551 0617 
 
                Alternatively please visit our website at www.ftserussell.com 
                        Terms of Use | Copyright (c) 2020 FTSE Russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

FTSUBANRRNUUAAR

(END) Dow Jones Newswires

February 17, 2020 12:30 ET (17:30 GMT)

Summit Therapeutics (LSE:SUMM)
過去株価チャート
から 12 2024 まで 1 2025